ConductScience.org, home

Paper8922256

Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.

Munch-Ellingsen J and 2 others. Basic Res Cardiol, 1996. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning. Papers, record 8922256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8922256

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blockade of the KATP-channel by glibenclamide aggravates ischemic injury, and counteracts ischemic preconditioning.
PubMed
Journal
Basic Res Cardiol
PubMed
Year
1996
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2019-09-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Munch-Ellingsen JJ
2Bugge EE
3Ytrehus KK

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlyburideMajor topic
Hypoglycemic AgentsMajor topic
Ischemic Preconditioning, MyocardialMajor topic
Myocardial InfarctionMajor topic
Potassium Channel BlockersMajor topic
Animals
Female
Hemodynamics
Male
Rabbits

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11415759Ischemic preconditioning protects against infarction in rat heart.Am J Physiol1992https://conductscience.org/library/papers/1415759PubMed
21310443Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.Circ Res1992https://conductscience.org/library/papers/1310443PubMed
38324795Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.Cardiovasc Res1993https://conductscience.org/library/papers/8324795PubMed
48380263Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts.Circ Res1993https://conductscience.org/library/papers/8380263PubMed
58124811A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels.Circulation1994https://conductscience.org/library/papers/8124811PubMed
68072020Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium.J Mol Cell Cardiol1994https://conductscience.org/library/papers/8072020PubMed
71750525Adenosine triphosphate-sensitive potassium channels in the cardiovascular system.Am J Physiol1991https://conductscience.org/library/papers/1750525PubMed
81836311Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts.Am J Physiol1991https://conductscience.org/library/papers/1836311PubMed
91908355Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle.Circ Res1991https://conductscience.org/library/papers/1908355PubMed
108044938Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.Circulation1994https://conductscience.org/library/papers/8044938PubMed
118160817Preconditioning protects ischemic rabbit heart by protein kinase C activation.Am J Physiol1994https://conductscience.org/library/papers/8160817PubMed
121593462ATP-sensitive K+ channels and cellular K+ loss in hypoxic and ischaemic mammalian ventricle.J Physiol1992https://conductscience.org/library/papers/1593462PubMed
132122259Modification by glibenclamide of the electrophysiological consequences of myocardial ischaemia in dogs and rabbits.Naunyn Schmiedebergs Arch Pharmacol1990https://conductscience.org/library/papers/2122259PubMed
148585864Perfusion delay causes unintentional ischemic preconditioning in isolated heart preparation.Basic Res Cardiol1995https://conductscience.org/library/papers/8585864PubMed
152102815Regulation of the ATP-sensitive potassium channel.Ion Channels1990https://conductscience.org/library/papers/2102815PubMed
168324799Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels.Cardiovasc Res1993https://conductscience.org/library/papers/8324799PubMed
172440431The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cells.Biochem Biophys Res Commun1987https://conductscience.org/library/papers/2440431PubMed
187943380Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine.Am J Physiol1994https://conductscience.org/library/papers/7943380PubMed
191762089The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.J Pharmacol Exp Ther1991https://conductscience.org/library/papers/1762089PubMed
202456760The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes.Biochem Biophys Res Commun1988https://conductscience.org/library/papers/2456760PubMed

See all 35 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
28545784Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Trends Endocrinol Metab2017https://conductscience.org/library/papers/28545784PubMed
18055876Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling.J Pharmacol Exp Ther2008https://conductscience.org/library/papers/18055876PubMed
17468933SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.Basic Res Cardiol2007https://conductscience.org/library/papers/17468933PubMed
12746224Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs.Br J Pharmacol2003https://conductscience.org/library/papers/12746224PubMed
9774180Equal reduction in infarct size by ethylisopropyl-amiloride pretreatment and ischemic preconditioning in the in situ rabbit heart.Mol Cell Biochem1998https://conductscience.org/library/papers/9774180PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8922256

GET https://conductscience.org/api/papers/v1/8922256/references?page=2